Objective: To assess depth and quality of sedation and the ability to place an intravenous catheter in cats after intramuscular (IM) injection with alfaxalone-methadone-midazolam (AMM) or ketamine-methadone-midazolam (KMM).
Study Design: Blinded randomized clinical trial.
Animals: A group of 46 healthy Domestic Short Hair cats.